1. Home
  2. GCO vs OABI Comparison

GCO vs OABI Comparison

Compare GCO & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genesco Inc.

GCO

Genesco Inc.

HOLD

Current Price

$26.98

Market Cap

284.2M

ML Signal

HOLD

Logo OmniAb Inc.

OABI

OmniAb Inc.

HOLD

Current Price

$1.75

Market Cap

277.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GCO
OABI
Founded
1924
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
284.2M
277.8M
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
GCO
OABI
Price
$26.98
$1.75
Analyst Decision
Buy
Strong Buy
Analyst Count
3
3
Target Price
$31.33
$6.67
AVG Volume (30 Days)
194.9K
311.5K
Earning Date
03-05-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,606,898,000.00
N/A
Revenue This Year
$5.42
N/A
Revenue Next Year
$2.41
$66.20
P/E Ratio
N/A
N/A
Revenue Growth
13.71
N/A
52 Week Low
$16.19
$1.22
52 Week High
$38.95
$3.52

Technical Indicators

Market Signals
Indicator
GCO
OABI
Relative Strength Index (RSI) 42.43 46.29
Support Level $25.56 $1.69
Resistance Level $29.79 $1.75
Average True Range (ATR) 1.43 0.09
MACD -0.14 0.01
Stochastic Oscillator 41.79 44.90

Price Performance

Historical Comparison
GCO
OABI

About GCO Genesco Inc.

Genesco Inc. sells footwear, headwear, sports apparel, and accessories through four main segments. The Journeys Group generates the highest revenue, encompassing the Journeys, Journeys Kidz, and Little Burgundy brands, along with e-commerce and catalog sales. The Schuh Group targets teenagers and young adults aged 16 to 24, focusing on casual and athletic footwear. The Johnston & Murphy Group operates retail shops and factory stores across the United States. Finally, the Genesco Brands Group designs and sources licensed footwear for brands like Levi's, Dockers, and G.H. Bass.

About OABI OmniAb Inc.

OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.

Share on Social Networks: